P. Roy Vagelos, Chairman of the Board at REGENERON PHARMACEUTICALS INC (REGN), sold 99,770 shares at $480.62 ($47.3M) on 2017-08-22, disclosed to the SEC on 2017-08-23.
Open-market sale of $47.3M REGN by Chairman of the Board. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $470.23 | 22,118 | $10.4M | 22.0% |
| 2 | $470.23 | 22,118 | $10.4M | 22.0% |
| 3 | $471.09 | 1,951 | $919K | 1.9% |
| 4 | $471.09 | 1,951 | $919K | 1.9% |
| 5 | $472.16 | 200 | $94K | 0.2% |
| 6 | $470.64 | 400 |
| $188K |
| 0.4% |
| 7 | $471.63 | 600 | $283K | 0.6% |
| 8 | $472.67 | 900 | $425K | 0.9% |
| 9 | $473.65 | 200 | $95K | 0.2% |
| 10 | $474.64 | 2,400 | $1.1M | 2.4% |
| 11 | $475.49 | 5,610 | $2.7M | 5.6% |
| 12 | $475.49 | 5,610 | $2.7M | 5.6% |
| 13 | $476.46 | 5,744 | $2.7M | 5.8% |
| 14 | $476.46 | 5,744 | $2.7M | 5.8% |
| 15 | $477.52 | 3,473 | $1.7M | 3.5% |
| 16 | $477.52 | 3,473 | $1.7M | 3.5% |
| 17 | $478.51 | 1,600 | $766K | 1.6% |
| 18 | $479.63 | 600 | $288K | 0.6% |
| 19 | $480.62 | 5,250 | $2.5M | 5.3% |
| 20 | $481.37 | 4,661 | $2.2M | 4.7% |
| 21 | $481.37 | 4,661 | $2.2M | 4.7% |
| 22 | $482.72 | 400 | $193K | 0.4% |
| 23 | $483.00 | 106 | $51K | 0.1% |
| Total | $474.07 avg | 99,770 | $47.3M | 100% |
| Filing → |
| REGN | SELL | 2020-08-13 | $39.7M | — | Filing → |
| REGN | SELL | 2020-05-22 | $847K | — | Filing → |
| REGN | SELL | 2020-05-22 | $168.0M | — | Filing → |